HSKA 119.99 (+0%)
US42805E3062Medical Diagnostics & ResearchDiagnostics & Research

Heska (HSKA) Competitor Comparison

We are evaluating the key criteria listed to compare Heska (HSKA) against its competitors in the Diagnostics & Research industry.

Performance 5 years - HSKA ranking 21 / 58

These are the competitors of Heska in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
681.01
2. Natera NTRA
412.6
3. RadNet RDNT
363.23
4. Medpace Holdings MEDP
261.44
5. Meridian Bioscience VIVO
118.46
6. Quest Diagnostics DGX
82.68
7. Fulgent Genetics FLGT
80.09
8. Laboratory Corp of America Holdings LH
74.28
9. Waters WAT
67.79
10. DarioHealth DRIO
61.4
11. IDEXX Laboratories IDXX
53.47
12. PerkinElmer PKI
48.44
13. Danaher DHR
47.84
14. Mettler-Toledo MTD
45.01
15. Twist Bioscience TWST
44.53
16. Anixa Biosciences ANIX
39.46
17. Thermo Fisher Scientific TMO
39.37
18. Agilent Technologies A
32.63
19. IQVIA Holdings IQV
14.25
20. Ortho Clinical Diagnostics Holdings OCDX
13.74
21. Heska HSKA
12.14
22. Qiagen QGEN
6.47
23. Co-Diagnostics CODX
6.45
24. DexCom DXCM
-5.47
25. Icon ICLR
-6.05
26. CareDx CDNA
-13.08
27. Syneos Health SYNH
-16.98
28. Olink Holding OLK
-26.82
29. Charles River Laboratories CRL
-27.76
30. Exact Sciences EXAS
-33.35
31. Guardant Health GH
-34.39
32. Myriad Genetics MYGN
-47.26
33. Bioventus BVS
-50.46
34. Pacific Biosciences of California PACB
-52.28
35. Precipio PRPO
-54.35
36. Psychemedics PMD
-59.35
37. Personalis PSNL
-60.19
38. Inotiv NOTV
-60.42
39. Sotera Health SHC
-61.07
40. Enzo Biochem ENZ
-65.26
41. NeoGenomics NEO
-65.42
42. Exagen XGN
-70.37
43. Illumina ILMN
-72.73
44. National Research NRC
-77.07
45. Sera Prognostics SERA
-78.35
46. Trinity Biotech TRIB
-81.02
47. Neogen NEOG
-82.02
48. MaxCyte MXCT
-84.81
49. Global Cord Blood CO
-86.47
50. Interpace Biosciences IDXG
-86.51
51. MDxHealth MDXH
-87.08
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.99

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.